Original InvestigationBicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Kim has received proctor or speaker fees from Abbott, Boston Scientific, Edwards Lifesciences, and Medtronic. Dr. Victoria has received speaker fees from Abbott Vascular, Medtronic, Edwards Lifesciences, GE Healthcare, and Merck Sharp & Dohme. Dr. Dhoble has served as a proctor and consultant for Abbott Vascular, Edwards Lifesciences, and Keystone Heart; and has served on the physician review committee for the Keystone Heart REFLECT trial. Dr. Babaliaros has received consulting fees from Edwards Lifesciences and Abbott Vascular; and has equity in Transmural Systems. Dr. Jilaihawi has served as a consultant for Boston Scientific and Medtronic; and has received research grants from Abbott Vascular, Edwards Lifesciences, Medtronic, and Bracco. Dr. Pilgrim has received research grants to the institution and speaker fees from Boston Scientific and Biotronik; and has received consultant fees from HighLife SAS. Dr. Backer has served as a consultant for Abbott and Boston Scientific. Dr. Renker has received speaker fees from Abbott. Dr. Pershad has received speaking fees and honoraria from Boston Scientific, Medtronic, Asahi Intecc, Edwards Lifesciences, and Abiomed; and has received consultancy fees from Abiomed and Boston Scientific. Dr. Chakravarty has received support from Edwards Lifesciences, Medtronic, and Abbott. Dr. Whisenant has served as a consultant for Edwards Lifesciences and Boston Scientific. Dr. Windecker has received research and educational grants to the institution from Abbott, Amgen, Bristol-Myers Squibb, Bayer, Boston Scientific, Biotronik, Cardinal Health, CardioValve, CSL Behring, Daiichi-Sankyo, Edwards Lifesciences, Johnson & Johnson, Medtronic, Querbet, Polares, Sanofi, Terumo, and Sinomed; serves as an unpaid member of the steering/executive group of trials funded by Abbott, Abiomed, Amgen, Bristol-Myers Squibb, Boston Scientific, Biotronik, Cardiovalve, Edwards Lifesciences, MedAlliance, Medtronic, Polares, Sinomed, V-Wave, and Xeltis, but has not received personal payments by any pharmaceutical company or device manufacturer; and has been member of the steering/executive committee group of several investigator-initiated trials that receive funding from industry without impact on his personal remuneration. Dr. Sondergaard has served as a proctor for and received institutional grants from Edwards Lifesciences. Dr. Chevalier has served as a consultant for Medtronic. Dr. Mack has received nonfinancial support from Edwards Lifesciences, Abbott, and Medtronic outside of the submitted work. Dr. Leon has received grants and other support from Edwards Lifesciences, Medtronic, and Boston Scientific outside of the submitted work. Dr. Makkar has received research grants and consulting and speaker fees from Edwards Lifesciences, Abbott, Medtronic, and Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.